Delivering mutual benefit from NHS and Pharma partnerships – grasping the opportunities

Roy Lilley is an established, independent health policy analyst, writer, broadcaster and commentator on health and social issues. Previously, a Visiting Fellow at the Management School, Imperial College London and formerly at the Centre for Health Services Management at the University of Nottingham, he also provides consultancy to NHS organisations and the companies that have services and products for the health service.

He has, twice, been voted top UK speaker on NHS topics and is the creator of the top selling 'Tool-Kit' series of books.

He was the vice-chairman of West Surrey and North East Hampshire Health Authority and formerly a member of Surrey Heath Borough Council holding the position of Mayor in 1988/89. Between 1991 and 1995, Roy was the chairman of the Homewood NHS Trust, Chertsey Surrey, a first wave Trust with responsibility for People with a Learning Disability and Mental Health problems.

Homewood is the only health provider in the world to have achieved British Standard 5750 for the whole of its services and the first NHS Trust to have achieved the coveted Investors in People Award for the whole of its human resource and training policies.

It was the only NHS establishment to have a 'no-strike' deal with its staff.

Roy Lilley was a founder member of the NHS Trust Federation and held the positions of Chairman of the Supplies and Purchasing Standing Committee and Chairmanship of the Standing Committee on HR Issues.

He has been a member of the NHS Steering Group on women's issues and a member of the NHS Training Executive's Group on training Boards and Non-Executive Directors.

Roy is a frequent broadcaster and writer on health, current affairs and social issues and speaks at conferences and seminars throughout the UK and overseas.

He has contributed to the Today Programme, Newsnight, the Midnight Hour, BBC News 24, BBC 5 Live, Channel 5 News, Sky, ITN and regional TV and radio programmes.

He has written for the Guardian, Sunday Times, Telegraph and many national newspapers, journals and management periodicals including a regular column in Pharmaceutical Marketing magazine. He is the author of over twenty books on health and health service management and was appointed a Trustee of the Patient Choice initiative.

He was voted the top UK speaker in the Partnerships for Healthcare speaker survey. He has been a guest speaker on management and related subjects at the Civil Service College, Sunningdale. He is a Freeman of the City of London, a Fellow of the Institute of Directors and a Fellow of the Royal Society of Arts.

Roy has held a variety of positions with clubs and societies, including:

the Surrey Heath Group of the British Heart Foundation; Mencap and the Savoy Singers; President of the Frimley & Camberley St John's Ambulance Cadets and formerly a trustee of the Surrey Heath Archaeology and Heritage Trust; a member of the Variety Club of Great Britain.

In November 2004 he was made a Companion of the Institute of Healthcare management for his 'outstanding contribution' to healthcare management.

He is a guitarist and magician and often uses these talents in his presentations!

In 2005 he started ballroom dancing and has a bronze medal in ballroom and Latin American dancing.

 

Chris qualified in Medicine and was a full-time GP in a Nottinghamshire mining village for 5 years, still working now part time in inner city Nottingham. He was appointed as a public health specialist in 1995 and has been Director of Public Health in Nottingham since 2001, leading the core public health functions of Health Protection, Health Improvement, and Improving Quality Healthcare. He was a Senior Clinical Lecturer at Nottingham University from 1995 to 2006; between 1998 and 2001 was UK lead on an EU-funded project on public health for healthcare managers at the French National School of Public Health in Rennes. He is currently also UK Chair of Examiners for the final professional examinations of the Faculty of Public Health, and Vice President of the UK Association of Directors of Public Health.

 

Omar Ali qualified with a hospital pharmacy background and is currently working as a Formulary Advisor to Surrey & Sussex Healthcare NHS Trust and is an Advisor to 3 Drugs & Therapeutics Committees in the South of England.

Omar is a Senior Lecturer at the University of Portsmouth PGDip/MSc Pharmacy Programme and last year became both Lecturer & Examiner/Invigilator on the Non Medical Prescribing V300 Course at the University of Surrey. He has over 25 publications to date (obesity, diabetes, hypertension, GORD & health economics) and has authored 2 booklets on implementation of NICE Guidance & TAG documents.

Omar has spoken at various Medical Conferences within the UK, Europe and occasionally further a field and has been appointed to the NHS Advisory Board for Pharmaceutical Field Magazine. Having been an executive board member for the National Obesity Forum, Omar is now a council member for the charity PCOS. He is an Editorial Content Adviser to Guidelines (national publication for NHS Medicines Management Teams) and also sits on the CPPE Advisory Board. Most recently, Omar has just been appointed a position on the Cost Impact Panel for the External Reference Committee for NICE.

 

Neal has a background as a general practitioner and medical education. He then spent seven years as a medical manager and part time GP before working as one of the early Clinical Editors of Clinical Evidence, BMJ Publications. He has written two books, numerous papers (a series of five published in the last few months), has a Masters in Prescribing Science, is a Fellow of the Royal College of General Practitioners, and since 2001 he has been a Director of the National Prescribing Centre.

 

Andrew is currently Head of NHS Partnership. Andrew joined Astra Zeneca in 2007 from Schering Plough where he had responsibility for developing and implementing approaches to partnership and collaborative working with the NHS. Andrew has 24 years experience in Pharmaceuticals with 13 years at GSK working in Sales, Marketing and Corporate Affairs before a 7 year period in UK and International Consultancy working in health economics, health outcomes and Market Access.

 

Andy is originally from Cumbria and was educated at Keswick School in the Lake District. After graduating in Biology Andy joined the pharmaceutical industry in 1989 and held several positions in sales, sales training and sales management before becoming National Sales Manager (NSM) at Parke Davis in 1996. In 1997 Andy was NSM at the launch of Lipitor and was subsequently promoted to Customer Business Unit Director in 1998.

In 2000 Andy was appointed Managing Director of Takeda UK Ltd when it was the 72nd largest company in the UK. Andy and his team pioneered the Regional Account Director model, which transformed the company and its performance. Takeda now sits at 13th in the same league table. In 2005 Andy joined a start up Virgin Group company as first employee and CEO. That business was launched in January 2007 and has successfully internationalised with a new base in Qatar. After a period of 5 years out of the pharmaceutical industry Andy has joined Lundbeck as Sales Director. Andy has three children and lives with his wife Jan in Nottingham.

 

Sarah is Head of Health at Ipsos MORI Health. She has worked in pharmaceutical research for over 10 years, at a number of agencies, including Harris Interactive and Research International. She has lead the healthcare team at Ipsos MORI, since 2007 and has worked extensively with leading pharmaceutical companies in the UK and internationally.

Her focus is on bringing more innovative approaches to pharmaceutical research through the integration of Ipsos capabilities across different specialisms, for instance bringing learnings from the consumer world into pharmaceuticals and leveraging the expertise and knowledge of the Ipsos Social Research Institute in the pharmaceutical market.

Sarah's remit is to facilitate execution of data for clients in a more creative manner, to ensure that findings are clearly understood and actions and next steps visible from the research design.

She regularly presents at conferences and events and was delighted to receive the award for best conference paper at this years' European Pharmaceutical Market Research Conference (EphMRA) in Berlin.